Dual-antiplatelet therapy after stenting

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Background

Optimum duration of dual antiplatelet treatment (DAPT) after coronary stenting remains uncertain, with an unknown efficacy to safety ratio of extended treatment leading to discrepancies between international guidelines and clinical practice. We assessed whether DAPT continuation b...